Literature DB >> 6338032

Microenzyme-linked immunosorbent assay for detection of immunoglobulin G and immunoglobulin M antibodies to Legionella pneumophila.

E M Elder, A Brown, J S Remington, J Shonnard, Y Naot.   

Abstract

The microenzyme-linked immunosorbent assay (ELISA) for the detection of immunoglobulin M and G (IgM, IgG) antibodies to Legionella pneumophila serogroup 1 antigens was evaluated. IgM antibodies were measured by both double-sandwich and single-sandwich techniques. These assays were compared with the previously standardized indirect immunofluorescence test in four groups of subjects: (i) pneumonia patients with culture-proven Legionnaires disease with serogroup 1 isolates, (ii) pneumonia patients with serogroup 1 organisms detected by direct immunofluorescence testing of respiratory secretions but without culture confirmation, (iii) pneumonia patients with negative culture and direct immunofluorescence tests, and (iv) healthy hospital employees. In addition, the sensitivity and specificity of the IgG ELISA were evaluated with larger groups of controls and Legionnaires disease patients. The ELISA was more sensitive than the indirect immunofluorescence test. However, it detected antibody rises in pneumonia patients without culture or direct immunofluorescence evidence of L. pneumophila serogroup 1 infection, thereby suggesting that the specificity of the ELISA was slightly lower than that of the indirect immunofluorescence test. The double-sandwich ELISA was a sensitive method for detecting IgM antibodies and, as previously reported, appeared to be free from interference by rheumatoid factor. IgM anti-Legionella antibodies detected by the ELISA appeared earlier and were less persistent than IgG antibodies. In addition, the IgM ELISA was useful in detecting antibodies in necropsy serum samples obtained from patients dying acutely of Legionnaires disease. The data presented show that the ELISA is a reliable method for the detection of specific anti-Legionella antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338032      PMCID: PMC272585          DOI: 10.1128/jcm.17.1.112-121.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Serology of Legionnaires disease: comparison of indirect fluorescent antibody, immune adherence hemagglutination, and indirect hemagglutination tests.

Authors:  D A Lennette; E T Lennette; B B Wentworth; M L French; G L Lattimer
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

3.  Use of a semiselective medium to culture Legionella pneumophila from contaminated lung specimens.

Authors:  P H Edelstein; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

4.  Ubiquitousness of Legionella pneumophila in the water supply of a hospital with endemic Legionnaires' disease.

Authors:  J Stout; V L Yu; R M Vickers; J Zuravleff; M Best; A Brown; R B Yee; R Wadowsky
Journal:  N Engl J Med       Date:  1982-02-25       Impact factor: 91.245

5.  Slide agglutination test for serogrouping Legionella pneumophila and atypical Legionella-like organisms.

Authors:  H W Wilkinson; B J Fikes
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

6.  The antibody response in Legionnaires' disease.

Authors:  J Nagington; T G Wreghitt; J O Tobin; A D Macrae
Journal:  J Hyg (Lond)       Date:  1979-10

7.  Direct immunofluorescent detection of Legionella pneumophila in respiratory specimens.

Authors:  W C Winn; W B Cherry; R O Frank; C A Casey; C V Broome
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

8.  Serological and genotypic diversity among serogroup 5- reacting environmental Legionella isolates.

Authors:  G M Garrity; E M Elder; B Davis; R M Vickers; A Brown
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

9.  Cross-reaction to Legionella pneumophila antigen in sera with elevated titers to Pseudomonas pseudomallei.

Authors:  G C Klein
Journal:  J Clin Microbiol       Date:  1980-01       Impact factor: 5.948

10.  Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila.

Authors:  J C Feeley; R J Gibson; G W Gorman; N C Langford; J K Rasheed; D C Mackel; W B Baine
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

View more
  7 in total

1.  Value of serological testing for diagnosis of legionellosis in outbreak patients.

Authors:  Almudena Rojas; M Dolores Navarro; Francisca E Fornés; Estefanía Serra; Encarnación Simarro; José Rojas; Joaquín Ruiz
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 2.  Diagnosis of Legionella infection in Legionnaires' disease.

Authors:  J W Den Boer; E P F Yzerman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

3.  Antigenic specificity of the antibody response in humans during legionellosis.

Authors:  A Brown; M W Lema; M S Brown-Schlumpf
Journal:  Infection       Date:  1986 May-Jun       Impact factor: 3.553

4.  Seroprevalence of Legionella in Shanxi Province, China.

Authors:  J Wang; M S Brown-Schlumpf; A Brown; X Z Xie
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

Review 5.  Laboratory diagnosis of infections caused by legionellae.

Authors:  P H Edelstein
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

6.  Antibody response to dengue-2 vaccine measured by two different radioimmunoassay methods.

Authors:  P L Summers; K H Eckels; J M Dalrymple; R M Scott; V A Boyd
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

7.  Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia.

Authors:  T J Marrie; D Raoult; B La Scola; R J Birtles; E de Carolis
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.